Another small-molecule inhibitor, NMS-P715 has previously been shown to inhibit TTK expression in medulloblastoma, resulting in suppression of cell growth and clonogenic potential, as well as induction of apoptosis, further reaffirming our findings from the current study [49]. The gene discussed is TTK; the disease is medulloblastoma.